Variant report
Variant | nsv599610 |
---|---|
Chromosome Location | chr5:120424662-120460548 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:120430789..120432374-chr5:120435217..120437128,2 | K562 | blood: | |
2 | chr5:120430789..120432374-chr5:120435217..120437128,2 | K562 | blood: | |
3 | chr5:120435633..120438376-chr5:120443596..120446057,2 | MCF-7 | breast: | |
4 | chr5:120435633..120438376-chr5:120443596..120446057,2 | MCF-7 | breast: | |
5 | chr5:120449899..120451786-chr5:120452739..120454812,2 | K562 | blood: | |
6 | chr5:120449899..120451786-chr5:120452739..120454812,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11960097 | chr5:120424662-120424663 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs35431298 | chr5:120424673-120424674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530479206 | chr5:120424702-120424703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75418733 | chr5:120424713-120424714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4145736 | chr5:120424719-120424720 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs116701136 | chr5:120424741-120424742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs36004236 | chr5:120424880-120424881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546070361 | chr5:120424888-120424889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143002201 | chr5:120424897-120424898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35106904 | chr5:120424901-120424902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546807784 | chr5:120424947-120424948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369126490 | chr5:120424966-120424967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571332131 | chr5:120425047-120425048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182406852 | chr5:120425147-120425148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186767714 | chr5:120425157-120425158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575241396 | chr5:120425158-120425159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10069124 | chr5:120425174-120425175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536197651 | chr5:120425198-120425199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143976840 | chr5:120425246-120425247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200109025 | chr5:120425280-120425281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201131798 | chr5:120425288-120425289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs67152381 | chr5:120425290-120425291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs367561829 | chr5:120425293-120425294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148193165 | chr5:120425306-120425307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs966453 | chr5:120425307-120425308 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs190685747 | chr5:120425323-120425324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565522783 | chr5:120425353-120425354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549542740 | chr5:120425377-120425378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577356870 | chr5:120425380-120425381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532239148 | chr5:120425385-120425386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544899864 | chr5:120425386-120425387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562993948 | chr5:120425394-120425395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs397819452 | chr5:120425396-120425397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs966452 | chr5:120425411-120425412 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs74318462 | chr5:120425428-120425429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560852391 | chr5:120425443-120425444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184225989 | chr5:120425500-120425501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73789535 | chr5:120425502-120425503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528222280 | chr5:120425531-120425532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568471546 | chr5:120425539-120425540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571457748 | chr5:120425544-120425545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538413479 | chr5:120425556-120425557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549565996 | chr5:120425595-120425596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140238811 | chr5:120425601-120425602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377644204 | chr5:120425657-120425658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377495077 | chr5:120425658-120425659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs56816041 | chr5:120425661-120425662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536127779 | chr5:120425679-120425680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554574494 | chr5:120425689-120425690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369127498 | chr5:120425695-120425696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120424400-120425400 | Weak transcription | Dnd41 | blood |
2 | chr5:120425400-120427000 | Enhancers | Dnd41 | blood |
3 | chr5:120440400-120440800 | Enhancers | Spleen | Spleen |
4 | chr5:120442200-120442800 | ZNF genes & repeats | Dnd41 | blood |
5 | chr5:120442800-120444000 | Weak transcription | Dnd41 | blood |
6 | chr5:120443000-120447600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr5:120443400-120445000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:120443800-120444000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:120444000-120444400 | ZNF genes & repeats | Dnd41 | blood |
10 | chr5:120444000-120444600 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
11 | chr5:120444000-120444600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr5:120444000-120444800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
13 | chr5:120444200-120444400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
14 | chr5:120444200-120444600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr5:120444400-120444600 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
16 | chr5:120444400-120444800 | Enhancers | Placenta | Placenta |
17 | chr5:120444400-120444800 | Active TSS | Hela-S3 | cervix |
18 | chr5:120444400-120445600 | Enhancers | Dnd41 | blood |
19 | chr5:120444600-120444800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr5:120445000-120449000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr5:120447600-120447800 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr5:120449000-120449600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr5:120449600-120450200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |